keyword
https://read.qxmd.com/read/38551548/class-1c-antiarrhythmics-for-premature-ventricular-complex-suppression-in-nonischemic-cardiomyopathy-with-implantable-cardioverter-defibrillators
#21
JOURNAL ARTICLE
Mohamad Raad, Haran Yogasundaram, Justice Oranefo, Gustavo Guandalini, Timothy Markman, Matthew Hyman, Robert Schaller, Gregory Supple, Rajat Deo, Saman Nazarian, Michael Riley, David Lin, Fermin Garcia, Sanjay Dixit, Andrew E Epstein, David Callans, Francis E Marchlinski, David S Frankel
BACKGROUND: Premature ventricular complexes (PVCs) are common and associated with worse outcomes in patients with heart failure. Class 1C antiarrhythmic drugs (AADs) effectively suppress PVCs, but guidelines currently restrict their use in structural heart disease. OBJECTIVES: This study aimed to assess the safety and efficacy of class 1C AADs in patients with nonischemic cardiomyopathy (NICM) and implantable cardioverter-defibrillators (ICDs). METHODS: All patients with NICM and an ICD treated with flecainide or propafenone at the Hospital of the University of Pennsylvania between 2014 and 2022 were identified...
March 5, 2024: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/38550516/the-arrhythmic-presentation-of-peripartum-cardiomyopathy-case-series-and-critical-review-of-the-literature
#22
JOURNAL ARTICLE
Giovanni Peretto, Emanuele Micaglio, Giuseppe Ciconte, Marianna Maia, Martina Luzzi, Marianna Cariello, Adele Gabriella Rosa Bonfanti, Davide Lazzeroni, Luigi Anastasia, Paolo Cavoretto, Alaide Chieffo, Paolo Della Bella, Carlo Pappone
Peripartum Cardiomyopathy (PPCM) is a polymorphic myocardial disease occurring late during pregnancy or early after delivery. While reduced systolic function and heart failure (HF) symptoms have been widely described, there is still a lack of reports about the arrhythmic manifestations of the disease. Most importantly, a broad range of unidentified pre-existing conditions, which may be missed by general practitioners and gynecologists, must be considered in differential diagnosis. The issue is relevant since some arrhythmias are associated to sudden cardiac death occurring in young patients, and the overall risk does not cease during the early postpartum period...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38545606/an-international-survey-of-the-management-of-atrial-fibrillation-in-critically-unwell-patients
#23
JOURNAL ARTICLE
Brian W Johnston, Andrew A Udy, Daniel F McAuley, Martin Mogk, Ingeborg D Welters, Stephanie Sibley
OBJECTIVES: To evaluate the current management of new-onset atrial fibrillation and compare differences in practice regionally. DESIGN: Cross-sectional survey. SETTING: United States, Canada, United Kingdom, Europe, Australia, and New Zealand. SUBJECTS: Critical care attending physicians/consultants and fellows. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 386 surveys were included in our analysis...
April 2024: Critical care explorations
https://read.qxmd.com/read/38541919/cardiac-sarcoidosis-diagnostic-and-therapeutic-challenges
#24
REVIEW
Dennis Korthals, Michael Bietenbeck, Hilke Könemann, Florian Doldi, David Ventura, Michael Schäfers, Michael Mohr, Julian Wolfes, Felix Wegner, Ali Yilmaz, Lars Eckardt
Sarcoidosis is a multisystem disorder of unknown etiology. The leading hypothesis involves an antigen-triggered dysregulated T-cell-driven immunologic response leading to non-necrotic granulomas. In cardiac sarcoidosis (CS), the inflammatory response can lead to fibrosis, culminating in clinical manifestations such as atrioventricular block and ventricular arrhythmias. Cardiac manifestations frequently present as first and isolated signs or may appear in conjunction with extracardiac manifestations. The incidence of sudden cardiac death (SCD) is high...
March 15, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38540180/thyroid-dysfunction-in-advanced-heart-failure-patients-and-its-correlation-with-amiodarone-therapy-a-two-year-study
#25
JOURNAL ARTICLE
Agnieszka Kuczaj, Szymon Warwas, Anna Danel, Piotr Przybyłowski, Tomasz Hrapkowicz
(1) Background: Advanced heart failure often accompanies ventricular arrhythmias, necessitating antiarrhythmic therapies. Amiodarone, commonly used for this purpose, may induce thyroid dysfunction due to its high iodine content. However, the prevalence and correlation of thyroid dysfunction with amiodarone in end-stage heart failure patients remain unclear. Aim: This study aimed to evaluate the prevalence and types of thyroid dysfunction and their association with amiodarone among 200 patients diagnosed with advanced heart failure eligible for transplantation...
March 3, 2024: Biomedicines
https://read.qxmd.com/read/38533836/validation-of-a-novel-smartphone-based-photoplethysmographic-method-for-ambulatory-heart-rhythm-diagnostics-the-smartbeats-study
#26
JOURNAL ARTICLE
Jonatan Fernstad, Emma Svennberg, Peter Åberg, Katrin Kemp Gudmundsdottir, Anders Jansson, Johan Engdahl
BACKGROUND AND AIMS: In the current guidelines, smartphone-photoplethysmography (PPG) is not recommended for diagnosis of atrial fibrillation (AF), without a confirmatory electrocardiogram (ECG) recording. Previous validation studies have been performed under supervision in healthcare settings, with limited generalizability of the results. We aim to investigate the diagnostic performance of a smartphone-PPG method in a real-world setting, with ambulatory unsupervised smartphone-PPG recordings, compared with simultaneous ECG recordings and including patients with atrial flutter (AFL)...
March 27, 2024: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://read.qxmd.com/read/38533301/impact-and-prevalence-of-comorbidities-and-complications-on-the-severity-of-covid-19-in-association-with-age-gender-obesity-and-pre-existing-smoking-a-meta-analysis
#27
REVIEW
Soulandi Djorwé, Amale Bousfiha, Néhémie Nzoyikorera, Joseph Nyandwi, Bellamine Kawthar, Abderrahim Malki
BACKGROUND: COVID-19 patients usually present multiple comorbidities and complications associated with severe forms of SARS-CoV-2 infection. This study aimed to assess the risk factors and prevalence of comorbidities and complications contributing to the severity of COVID-19. METHODS: This meta-analysis was performed according to PRISMA guidelines. We searched various databases, including PubMed, Google Scholar, and Scopus (between 2020 and 2023), for eligible studies for this meta-analysis...
2024: BioMedicine
https://read.qxmd.com/read/38523952/comparison-of-cardiovascular-outcomes-and-all-cause-mortality-between-patients-with-and-without-epilepsy-a-systematic-review-and-meta-analysis-of-observational-studies
#28
REVIEW
Azrung Fayaz, Mehnahil Raza, Areeba Khan, Pranav Mohandas, Hailegiorgis Getnet Ayalew, Prinka Perswani, Calvin R Wei, Mahmoud Ahmed Abdelbaki
This meta-analysis aimed to assess the all-cause mortality and cardiovascular outcomes among patients diagnosed with epilepsy. The entire process of this systematic review and meta-analysis adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to ensure transparency and reporting completeness. A comprehensive search strategy was employed to identify relevant studies in electronic databases, including PubMed, Embase, and the Cumulative Index of Nursing and Allied Health Literature (CINAHL), from January 1, 2010, to January 15, 2024...
February 2024: Curēus
https://read.qxmd.com/read/38516780/clinical-guideline-for-preimplantation-genetic-testing-in-inherited-cardiac-diseases
#29
JOURNAL ARTICLE
Job A J Verdonschot, Debby M E I Hellebrekers, Vanessa P M van Empel, Malou Heijligers, Sonja de Munnik, Edith Coonen, Jos C M F Dreesen, Arthur van den Wijngaard, Han G Brunner, Masoud Zamani Esteki, Stephane R B Heymans, Christine E M de Die-Smulders, Aimée D C Paulussen
BACKGROUND: Preimplantation genetic testing (PGT) is a reproductive technology that selects embryos without (familial) genetic variants. PGT has been applied in inherited cardiac disease and is included in the latest American Heart Association/American College of Cardiology guidelines. However, guidelines selecting eligible couples who will have the strongest risk reduction most from PGT are lacking. We developed an objective decision model to select eligibility for PGT and compared its results with those from a multidisciplinary team...
March 22, 2024: Circulation. Genomic and Precision Medicine
https://read.qxmd.com/read/38510995/clinical-course-of-adults-with-co-occurring-hypertrophic-cardiomyopathy-and-hypertension-a-scoping-review
#30
REVIEW
Milla Arabadjian, Sophie Montgomery, Mitchell Pleasure, Barnaby Nicolas, Maxine Collins, Maria Reuter, Daniele Massera, Daichi Shimbo, Mark V Sherrid
INTRODUCTION: Hypertension affects approximately 50 % of patients with hypertrophic cardiomyopathy (HCM) but clinical course in adults with co-occurring HCM and hypertension is underexplored. Management may be challenging as routine anti-hypertensive medications may worsen obstructive HCM, the most common HCM phenotype. In this scoping review, we sought to synthesize the available literature related to clinical course and outcomes in adults with both conditions and to highlight knowledge gaps to inform future research directions...
March 2024: American heart journal plus: cardiology research and practice
https://read.qxmd.com/read/38506312/genetic-risk-factors-for-drug-induced-long-qt-syndrome-findings-from-a-large-real-world-case-control-study
#31
JOURNAL ARTICLE
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Aim: Drug-induced long QT syndrome (diLQTS), an adverse effect of many drugs, can lead to sudden cardiac death. Candidate genetic variants in cardiac ion channels have been associated with diLQTS, but several limitations of previous studies hamper clinical utility. Materials & methods: Thus, the purpose of this study was to assess the associations of KCNE1 -D85N, KCNE2 -I57T and SCN5A -G615E with diLQTS in a large observational case-control study (6,083 self-reported white patients treated with 27 different high-risk QT-prolonging medications; 12...
March 20, 2024: Pharmacogenomics
https://read.qxmd.com/read/38505041/hybrid-ablation-for-persistent-atrial-fibrillation-a-narrative-review
#32
REVIEW
Shohei Kataoka, Morio Shoda, Koichiro Ejima, Ken Kato, Kyoichiro Yazaki, Shun Hasegawa, Masayuki Sakai, Satoshi Higuchi, Daigo Yagishita, Junichi Yamaguchi
BACKGROUND AND OBJECTIVE: Treatment for atrial fibrillation (AF) has evolved significantly, with pulmonary vein isolation (PVI) becoming an established treatment. However, the outcomes following catheter ablation for persistent AF remain unsatisfactory. Hybrid catheter-surgical ablation has emerged as a therapeutic approach for persistent AF, combining the strengths of both interventions. The purpose of this narrative review is to comprehensively examine the current state of knowledge regarding hybrid ablation for AF...
February 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38495288/predicting-major-adverse-cardiovascular-events-after-orthotopic-liver-transplantation-using-a-supervised-machine-learning-model-a-cohort-study
#33
JOURNAL ARTICLE
Jonathan Soldera, Leandro Luis Corso, Matheus Machado Rech, Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Fernanda Tomé, Nathalia Moraes, Rafael Sartori Balbinot, Santiago Rodriguez, Ajacio Bandeira de Mello Brandão, Bruno Hochhegger
BACKGROUND: Liver transplant (LT) patients have become older and sicker. The rate of post-LT major adverse cardiovascular events (MACE) has increased, and this in turn raises 30-d post-LT mortality. Noninvasive cardiac stress testing loses accuracy when applied to pre-LT cirrhotic patients. AIM: To assess the feasibility and accuracy of a machine learning model used to predict post-LT MACE in a regional cohort. METHODS: This retrospective cohort study involved 575 LT patients from a Southern Brazilian academic center...
February 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38491744/cardiac-sarcoidosis-with-extensive-and-heterogeneous-left-ventricular-fdg-uptake-in-absence-of-guidelines-indication-for-an-implantable-defibrillator-ventricular-tachycardia-precipitated-by-immunosuppressive-therapy-should-we-have-done-differently
#34
Emile Voisine, Sylvain Lemay, Jonathan Beaudoin, Philippe Jacob, François Philippon, Laurie Marchand, Bastien Vallée-Marcotte, Florence Bernier, Claudine Laliberté, Sophie Fortin, Marie-Ève Komlosy, David H Birnie, Mario Sénéchal
A 40-year-old man, newly diagnosed with cardiac sarcoidosis (CS) presented with symptomatic ventricular tachycardia three days after starting steroid-based immunosuppressive therapy (IT). There was no clear guideline indication for implantable cardioverter-defibrillator (ICD) before the initiation of IT. Shortly after ICD implantation and the initiation of anti-arrhythmic drugs, recurring ventricular arrhythmias required titration of the anti-arrhythmic drug therapy. One-year follow-up assessment showed no significant arrhythmias and complete PET scan FDG uptake suppression...
March 15, 2024: Pacing and Clinical Electrophysiology: PACE
https://read.qxmd.com/read/38491532/trastuzumab-in-patients-with-breast-cancer-and-pre-existing-left-ventricular-systolic-dysfunction
#35
JOURNAL ARTICLE
Azin Alizadehasl, Mina Mohseni, Kamran Roudini, Parisa Firoozbakhsh
BACKGROUND: Trastuzumab is one of the most effective treatments in HER-2 positive breast cancer patients. However, it is associated with development of cardiomyopathy/heart failure (HF) which is often a limiting side effect and associated with overall adverse outcomes. As a result, patients with pre-existing LV systolic dysfunction (LVSD) are often excluded from receiving anti-HER-2 therapy, which may lead to less effective cancer treatment and worse prognosis. OBJECTIVES: The current study aims to evaluate the safety of trastuzumab in patients with HER-2 positive breast cancer and pre-existing LVSD...
March 15, 2024: Cardio-Oncology
https://read.qxmd.com/read/38465648/cardiovascular-management-of-patients-undergoing-hematopoietic-stem-cell-transplantation-from-pretransplantation-to-survivorship-a-scientific-statement-from-the-american-heart-association
#36
REVIEW
Salim S Hayek, Vlad G Zaha, Carmel Bogle, Anita Deswal, Amelia Langston, Seth Rotz, Alexi Vasbinder, Eric Yang, Tochukwu Okwuosa
Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular evaluations are crucial in pretransplantation assessments, but guidelines are lacking. This American Heart Association scientific statement summarizes the data on transplantation-related complications and provides guidance for the cardiovascular management throughout transplantation. Hematopoietic stem cell transplantation consists of 4 phases: pretransplantation workup, conditioning therapy and infusion, immediate posttransplantation period, and long-term survivorship...
March 11, 2024: Circulation
https://read.qxmd.com/read/38458770/expanded-application-of-wearable-cardioverter-defibrillators-beyond-current-guidelines-proposal-for-a-european-register-explained-through-single-clinical-scenarios
#37
JOURNAL ARTICLE
Veronica Buia, Francesco Ciotola, Dirk Bastian, Dorina Stangl, Janusch Walascheck, Harald Rittger, Laura Vitali-Serdoz
The wearable cardioverter defibrillator (WCD) is becoming a more and more widely used instrument for the prevention of sudden cardiac death of patients either with a secondary prevention implantable cardioverter defibrillator indication or with a transient high risk of sudden cardiac death. Although clinical practice has demonstrated a benefit of protecting patients for a period as long as 3-6 months with such devices, the current European guidelines concerning ventricular arrhythmias and sudden cardiac death are still extremely restrictive in the patient selection in part because of the costs derived from such a prevention device, in part because of the lack of robust randomised trials...
March 8, 2024: Open Heart
https://read.qxmd.com/read/38456399/relationship-of-mild-to-moderate-impairment-of-left-ventricular-ejection-fraction-with-fatal-ventricular-arrhythmic-events-in-cardiac-sarcoidosis
#38
JOURNAL ARTICLE
Yuka Akama, Yudai Fujimoto, Yuya Matsue, Daichi Maeda, Kenji Yoshioka, Taishi Dotare, Tsutomu Sunayama, Takeru Nabeta, Yoshihisa Naruse, Takeshi Kitai, Tatsunori Taniguchi, Shuntaro Sato, Hidekazu Tanaka, Takahiro Okumura, Yuichi Baba, Tohru Minamino
BACKGROUND: Current guidelines recommend placing an implantable cardiac defibrillator for patients with cardiac sarcoidosis and a severely impaired left ventricular ejection fraction (LVEF) of ≤35%. In this study, we determined the association between mild or moderate LVEF impairment and fatal ventricular arrhythmic event (FVAE). METHODS AND RESULTS: We retrospectively analyzed 401 patients with cardiac sarcoidosis without sustained ventricular arrhythmia at diagnosis...
March 8, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38455609/pneumonectomy-for-severe-post-tuberculosis-bronchiectasis-a-successful-of-case-report-and-review-of-the-long-term-outcome
#39
JOURNAL ARTICLE
Putri O Zulfa, Yopie A Habibie
Limited clinical intervention studies highlight the absence of evidence-based international guidelines for effectively managing post-tuberculosis lung disease, emphasizing bronchiectasis. The aim of this study was to describe a case of left pneumonectomy for severe post-tuberculosis cystic bronchiectasis and to provide a review of the post-surgical mortality rate, complications, survival rate, and the patient's quality of life following the pneumonectomy procedure. A 36-year-old Indonesian male smoker presented with worsening breathing difficulties and fever...
December 2023: Narra J
https://read.qxmd.com/read/38453002/atrial-arrhythmias-in-patients-with-pulmonary-hypertension
#40
REVIEW
Kyle O'Meara, Gregory Stone, Eric Buch, Adam Brownstein, Rajan Saggar, Richard Channick, Alexander E Sherman, Aron Bender
TOPIC IMPORTANCE: Atrial arrhythmia (AA) are common in patients with pulmonary hypertension (PH) and contribute to morbidity and mortality. Given the growing PH population, it is important to understand the pathophysiology, clinical impact, and management of AA in PH. REVIEW FINDINGS: AA occurs in PH with a five-year incidence of 10-25%. AA confers a higher morbidity and mortality, and restoration of normal sinus rhythm improves survival and functionality. AA is thought to develop due to structural alterations of the right atrium caused by changes to the right ventricle (RV) due to elevated pulmonary artery pressures...
March 5, 2024: Chest
keyword
keyword
120851
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.